Clinical Trials Browser

Phase 3 × Carcinoma × Ipilimumab × Clear all

NCT03937219 2025-09-10

COSMIC-313

Phase 3 Active not recruiting

855 enrolled 12 charts

Carcinoma, Carcinoma, Renal Cell, Neoplasms